Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters

Journal of Gene Medicine

Volumn 9, Issue 11, 2007, Pages 956-966

  Tong, Yaw Chong ^a   Chang, Shwu Fen ^b   Liu, Chia Yang ^c   Kao, Winston W Y ^c   Huang, Chong Heng ^a   Liaw, Jiahorng ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Eye drops; Particle size; Polymeric micelles; Specific gene expression

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA GALACTOSIDASE; COPOLYMER; CYTOKERATIN 12; DEOXYRIBONUCLEASE I; EDETIC ACID; EYE DROPS; KERATIN; KERATOCAN; NANOCARRIER; PLASMID VECTOR; POLYMER; POLYOXYETHYLENE POLYOXYPROPYLENE POLYOXYETHYLENE COPOLYMER; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; ENDOCYTOSIS; ENZYME ACTIVITY; GENE EXPRESSION; GENOMIC INSTABILITY; LIGHT SCATTERING; MALE; MICELLE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARTICLE SIZE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; STAINING; TRANSGENE;

ANIMALS; CORNEA; CORNEAL DISEASES; DRUG DELIVERY SYSTEMS; GENE EXPRESSION; GENETIC VECTORS; KERATIN-12; MICE; MICELLES; NANOPARTICLES; OPHTHALMIC SOLUTIONS; POLYETHYLENE GLYCOLS; PROMOTER REGIONS (GENETICS); PROPYLENE GLYCOLS; PROTEOGLYCANS; RABBITS; TRANSGENES;

ANIMALIA; CYTOMEGALOVIRUS; MUS; ORYCTOLAGUS CUNICULUS;

EID: 36148962376     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1093     Document Type: Article

References (44)

1. Behrens A, Gordon EM, Li L, et al. Retroviral gene therapy vectors for prevention of excimer laser-induced corneal haze. Invest Ophthalmol Vis Sci 2002; 43: 968-977.
2. Rosenblatt MI, Azar DT. Gene therapy of the corneal epithelium. Int Ophthalmol Clin 2004; 44: 81-90.
3. Borrás T. Recent developments in ocular gene therapy. Exp Eye Res 2003; 76: 643-652. DOI: 10.1016/S0014-4835(03)00030-7.
4. Mohan RR, Sharma A, Netto MV, Sinha SS, Wilson SE. Gene therapy in the cornea. Prog Retin Eye Res 2005; 24: 537-559. DOI: 10.1016/ j.preteyeres.2005.04.001.
5. Jun AS, Larkin DFP. Prospects for gene therapy in corneal disease. Eye 2003; 17: 906-911. DOI: 10. 1038/sj.eye.6700565.
6. Yalin M, Oner F, Oner L, Hincal AA. Preparation and properties of a stable intravenous lorazepam emulsion. J Clin Pharm Ther 1997; 22: 39-44.
7. Yoon JK, Burgess DJ. Interfacial properties as stability predictors of lecithin-stabilized perfluorocarbon emulsions. Pharm Dev Technol 1996; 1: 333-341.
8. Thuret G, Manissolle C, Campos-Guyotat L, Guyotat D, Gain P. Animal compound-free medium and poloxamer for human corneal organ culture and dewelling. Invest Ophthalmol Vis Sci 2005; 46: 816-822. DOI: 10.1167/iovs.04-1078.
9. Pepic I, Jalsenjak N, Jalsenjak I. Micellar solutions of triblock copolymer surfactants with pilocarpine. Int J Pharm 2004; 272: 57-64. DOI: 10.1016/j.ijpharm.2003.11.032.
10. Portoles M, Refojo MF, Leong FL. Poloxamer 407 as a bacterial adhesive for hydrogel contact lenses. J Biomed Mater Res 1994; 28:303-309.
11. Firestone MA, Wolf AC, Seifert S. Small-angle X-ray scattering study of the interaction of poly(ethylene oxide)- b-poly(propylene oxide) -b-poly(ethylene oxide) triblock copolymers with lipid bilayers. Biomacromolecules 2003; 4: 1539-1549. DOI: 10.1021/ bmO34134r.
12. Liaw J, Chang SF, Hsiao FC. In vivo gene delivery into ocular tissues by eye drop of poly(ethylene oxide)- poly(propylene oxide) -poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles. Gene Ther 2001, 8: 999-1004.
13. Chang SF, Chang HY, Tong YC, et al. Nonionic polymeric micelles for oral gene delivery in vivo. Human Gene Ther 2004; 15:481-493.
14. Shiraishi A, Converse RL, Liu CY, Zhou F, Kao CWC, Kao WW. Identification of the cornea specific keratin 12 promoter by in vivo particle-mediated gene transfer. Invest Ophthalmol Vis Sci 1998; 39: 2554-2561.
15. Liu JJ, Kao WWY, Wilson SE. Corneal epithelium-specific mouse keratin K12 promoter. Exp Eye Res 1999; 68: 295-301.
16. Liu CY, Arar H, Kao C, Kao WWY. Identification of a 3.2 kb 5′-flanking region of the murine keratocan gene that directs β-galactosidase expression in the adult corneal stroma of transgenic mice. Gene 2000; 250: 85-96.
17. Carlson EC, Liu CY, Yang X, et al. In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte-specific promoter. Invest Ophthalmol Vis Sci 2004; 45: 2194-2200. DOI: 10.1167/iovs.03-1224.
18. Kinoshita S, Adachi W, Sotozono C, et al. Characteristics of the human ocular surface epithelium. Prog Retin Eye Res 2001; 20: 639-673.
19. MacGregor GR, Caskey CT. Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Res 1989; 17: 2365-2369.
20. Paris PL, Langenhan JM, Kool ET. Probing DNA sequences in solution with a monomer-excimer fluorescence color change. Nucleic Acids Res 1998; 26: 3789-3793,
21. Liaw J, Lin YC. Evaluation of poly(ethylene oxide)- poly(propylene oxide) -poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl. J Control Rel 2000; 68: 273-282. DOI: 10.1016/SO168-3659(00)00268-6.
22. Moret I, Peris JE, Guillem VM, et al. Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum. J Control Rel 2001; 76: 169-181.
23. Croyle MA, Walter E, Janich S, Roessler BJ, Amidon GL. Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium. Hum Gene Ther 1998; 9: 561-573.
24. Hanazono Y, Brown KE, Hnada. A, et al. In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectors. Blood 1999; 94: 2263-2270.
25. Brand C, Burkhardt E, Schaeffel F, Choi JW, Feldkaemper MP. Regulation of Egr-1, VIP, and Shh mRNA and Egr-1 protein in the mouse retina by light and image quality. Mol Vis 2005; 28: 309-320.
26. Oshima Y, Sakamoto T, Yamanaka I, Nishi T, Ishibashi T, Inomata. H. Targeted gene transfer to corneal endothelium. in vivo by electric pulse. Gene Ther 1998; 5: 1347-1354.
27. Wang D, Robinson DR, Kwon GS, Samuel J. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Control Rel 1999; 57: 9-18. DOI: 10.1016/SO168-3659(98)00099-6.
28. Rojanasakul Y, Liaw J, Robinsin JR. Mechanisms of action of some penetration enhancers in the cornea: laser scanning confocal microscopic and electrophysiology studies. Int J Pharm 1990; 66: 131-142.
29. Liaw J, Robinson JR. The effect of polyethylene glycol molecular weight on corneal transport and the related influence of penetration enhancers. Int J Pharm 1992; 88: 125-140.
30. Yang Z, Zhu J, Sriadibhatla S, Gebhart C, Alakhov V, Kabanov A. J Control Rel 2005; 108: 496-512. DOI: 10.1016/ j.jconrel.2005.08.015.
31. Sriadibhatla S, Yang Z, Gebhart C, Alakhov VYu, Kabanov A. Mol Ther 2006; 13: 804-813. DOI: 10.1016/j.ymthe.2005. 07.701.
32. Tsubota K, Inoue H, Ando K, Ono M, Yoshino K, Saito L. Adenovirus-mediated gene transfer to the ocular surface epithelium. Exp Eye Res 1998; 67: 531-538.
33. Spencer B, Agarwala S, Miskulin M, Smith M, Brandt CR. Herpes simplex virus-mediated gene delivery to the rodent visual system. Invest Ophthalmol Vis Sci 2000; 41: 1392-1401.
34. Blair-Parks K, Weston BC, Dean DA. High-level gene transfer to the cornea using electroporation. J Gene Med 2002; 4: 92-100. DOI: 10.1002/jgm.231.
35. Stechschulte SU, Joussen AM, von Recum HA, et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci 2001; 42: 1975-1979.
36. Mohan RR, Schultz GS, Hong JW, Mohan RR, Wilson SE. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for strmoal access. Exp Eye Res 2003; 76: 373-383. DOI: 10.1016/SO014-4835(02)00275-0.
37. Hämäläinen EM, Kananen K, Auriola S, Kontturi K, Urtti A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci 1997; 38: 627-634.
38. Liaw J, Aoyagi T, Kataoka K, Sakurai Y. Sakurai Y, Okano T. Permeation of PEO-PBLA-FITC polymeric micelles in aortic endothelial cells. Pharm Res 1999; 16: 213-220.
39. Batrakova EV, Li S, Miller DW, Kabanov AV. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm Res 1999; 16: 1366-1372.
40. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004; 377: 159-169. DOI: 10.1042/BJ20031253.
41. Scarborough RM, Rose JW, Naughton MA, et al. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J Biol Chem 1993; 268:1058-1065.
42. Collins L, Fabre JW. A synthetic peptide vector system for optimal gene delivery to corneal endothelium. J Gene Med 2004; 6: 185-194. DOI: 10. 1002/jgm.482.
43. Croyle MA, Walter E, Janich S, Roessler BJ, Amidon GL. Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium. Hum Gene Ther 1998; 9: 561-573.
44. Goldman M, Su Q, Wilson JM. Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis. Gene Ther 1996; 3: 811-818.